Showing 3141-3150 of 3223 results for "".
- Oculus Announces Release of Smartfield Smart Compact Perimeterhttps://modernod.com/news/oculus-announces-release-of-smartfield-smart-compact-perimeter/2479897/Oculus has announced the release of its Smartfield perimeter, expanding its portfolio of compact visual field testing devices. The new Smartfield has been optimized specifically for examinations for functional impairment of the central visual field, but is also suited for peripheral measurements.
- Innovative “Pay It Forward” Training Program for Specialty Eye Surgeonshttps://modernod.com/news/innovative-pay-it-forward-training-program-for-specialty-eye-surgeons/2479905/The Refractive Surgery Alliance (RSA) announced the creation of a new and innovative training program for vision correction surgeons. The RSA program structure is unique and recognizes the expanding and rapidly evolving field refractive surgery. Instead of training surgeons under a single
- Open-Angle Glaucoma in One Eye Likely to Develop in the Otherhttps://modernod.com/news/open-angle-glaucoma-in-one-eye-likely-to-develop-in-the-other/2479915/Patients with open-angle glaucoma in one eye are at increased risk for developing glaucoma in the second eye, researchers report, according to Reuters Health. “Among patients with newly diagnosed open-angle glaucoma, almost ha
- Lenstec Completes Enrollment of FDA Trial for SBL-3 IOLhttps://modernod.com/news/lenstec-completes-enrollment-of-fda-trial-for-sbl-3-iol/2479919/Lenstec announced that it has completed enrollment of the FDA trial for the SBL-3 IOL. The Lenstec SBL-3 IOL (segmented bifocal lens) is a non-concentric asymmetric multifocal refractive IOL that provides patients with superior near, intermediate, and distance vision. It also improves contrast se
- Joseph Gordon Named US President of Bausch + Lombhttps://modernod.com/news/joseph-gordon-named-us-president-of-bausch-lomb/2479922/Bausch + Lomb announced that Joseph Gordon has been named US president, Bausch + Lomb. In this role, Mr. Gordon will oversee the fully integrated U.S. eye care business, inclusive of all four business units – Vision Care, Consumer Health, Surgical, and Pharmaceuticals. He will report direct
- T-Cell Immune Responses Drive Neurodegeneration in Glaucomahttps://modernod.com/news/t-cell-immune-responses-drive-neurodegeneration-in-glaucoma/2479933/T-cell immune responses are partly responsible for progressive neurodegeneration in glaucoma, researchers report. “Current treatment of glaucoma is almost all focused on reducing intraocular pressure (IOP) and amelioration of
- Artificial Intelligence in Ophthalmology: A Brave New World Cominghttps://modernod.com/news/artificial-intelligence-in-ophthalmology-a-brave-new-world-coming/2479934/Artificial intelligence (AI) has been heralded as part of “the fourth industrial revolution,” along with Internet of Things, blockchain, and edge computing. All are methods of collecting, analyzing, and storing information and viewed as possessing the same life-changing potential as t
- Wills Eye Sponsors First Early Feasibility Study of a New Implantable Device for Blind Retinitis Pigmentosa Patientshttps://modernod.com/news/wills-eye-sponsors-first-us-early-feasibility-study-of-a-new-implantable-device-for-blind-retinitis-pigmentosa-patients/2479960/Wills Eye Hospital has been given FDA approval to begin an early feasibility study (EFS) to implant the RETINA IMPLANT Alpha AMS sub-retinal device in patients blind due to retinitis pigmentosa (RP). The Alpha AMS is manufactured by Retina Implant AG, Reutlingen,
- FDA Finalizes Guidance on Integrating EHRs Into Clinical Trialshttps://modernod.com/news/fda-finalizes-guidance-on-integrating-ehrs-into-clinical-trials/2479961/The FDA recently finalized an eagerly awaited guidance on the incorporation of electronic health records and real-world data into clinical trials and product submissions, including the use of patient medical histories, pharmacy records, radiology scans and lab test results from routine care, incl
- Glaucoma Research Foundation Grant Leads to Breakthrough in Neuron Regenerationhttps://modernod.com/news/glaucoma-research-foundation-grant-leads-to-breakthrough-in-neuron-regeneration/2479971/The Glaucoma Research Foundation announced a team of neuroscience researchers, led by Adriana Di Polo, PhD, at the University of Montreal, have made a major breakthrough in the treatment of glaucoma. The research, which was made possible by a Glaucoma Research Foundation Shaffer Grant, could also